SU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cells

Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity

(2012) Yun Chen et al.   Journal of Hematology & Oncology

Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns

(2012) A S Moore et al.   LEUKEMIA

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia

(2012) M Hofmann et al.   LEUKEMIA

Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia

(2012) R Swords et al.   LEUKEMIA

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

(2012) Catherine C. Smith et al.   NATURE

Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management

(2011) Elihu H. Estey   AMERICAN JOURNAL OF HEMATOLOGY

Current findings for recurring mutations in acute myeloid leukemia

(2011) Shinichiro Takahashi   Journal of Hematology & Oncology

Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications

(2011) Shinichiro Takahashi   Journal of Hematology & Oncology

FLT3 as a therapeutic target in AML: still challenging after all these years

(2010) T. Kindler et al.   BLOOD

Bench to Bedside Targeting of FLT3 in Acute Leukemia

(2010) Keith W. Pratz et al.   CURRENT DRUG TARGETS

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights

(2010) Xiongpeng Zhu et al.   Journal of Hematology & Oncology

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

(2009) P. P. Zarrinkar et al.   BLOOD

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics

(2009) Tara K Gregory et al.   Journal of Hematology & Oncology

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

(2008) Richard F. Schlenk et al.   NEW ENGLAND JOURNAL OF MEDICINE